NO991558L - Meningokokkvaksine som omfatter valensen til stamme BZ83 - Google Patents

Meningokokkvaksine som omfatter valensen til stamme BZ83

Info

Publication number
NO991558L
NO991558L NO991558A NO991558A NO991558L NO 991558 L NO991558 L NO 991558L NO 991558 A NO991558 A NO 991558A NO 991558 A NO991558 A NO 991558A NO 991558 L NO991558 L NO 991558L
Authority
NO
Norway
Prior art keywords
strain
tbpb
formula
sequence encoding
dna sequence
Prior art date
Application number
NO991558A
Other languages
English (en)
Other versions
NO991558D0 (no
Inventor
Marie-Josu Quentin-Millet
Bachra Rokbi
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of NO991558D0 publication Critical patent/NO991558D0/no
Publication of NO991558L publication Critical patent/NO991558L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Oppfinnelsen vedrører en farmasøytisk sammensetning som omfatter (i) subenheten av minste molekylære vekt (TbpB) av human transferrinreseptor (HTR) av en Neisserie meningilis-slamme som har en DNA-sekvens kodende for Tbp, (a) som inneholder to av Avall restriksjonsseter, 3 Hinchll restriksjonsseter, ingen Vspl restriksjonssete og ingen Xhol restriksjonssete eller (b) fra hvor det er mulig å utvikle ved PCR (polymerase- kjedereaksjon) ved å bruke primere P3 fra formelen 5'-AAGACCAACK}CGGATACGGTTTTGC-3' og P4 fra formelen 5'-GAAGACGAGTCGGAAACAAAGGGATG-3\ et polynukleotid på 765 ti! 775 nukletodier. En slik stamme er for eksempel BZ83-stamme hvor DNA-sekvensen koder for TbpB er vist i SEQ ID NO: l.
NO991558A 1997-08-07 1999-03-30 Meningokokkvaksine som omfatter valensen til stamme BZ83 NO991558L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9710301A FR2767060B1 (fr) 1997-08-07 1997-08-07 Vaccin meningocoque comportant la valence de souche bz83
PCT/FR1998/001730 WO1999007741A1 (fr) 1997-08-07 1998-08-03 Vaccin meningocoque comportant la valence de souche bz83

Publications (2)

Publication Number Publication Date
NO991558D0 NO991558D0 (no) 1999-03-30
NO991558L true NO991558L (no) 1999-03-30

Family

ID=9510254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991558A NO991558L (no) 1997-08-07 1999-03-30 Meningokokkvaksine som omfatter valensen til stamme BZ83

Country Status (10)

Country Link
EP (1) EP0948534A1 (no)
JP (1) JP2001503068A (no)
CN (1) CN1241193A (no)
AU (1) AU8987598A (no)
CA (1) CA2267066A1 (no)
FR (1) FR2767060B1 (no)
HU (1) HUP0001451A3 (no)
NO (1) NO991558L (no)
NZ (1) NZ334992A (no)
WO (1) WO1999007741A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
KR20160110368A (ko) * 2013-12-02 2016-09-21 안토니 비. 쉬라이버스 박테리아 표면 수용체 단백질로부터 유래된 면역원성 조성물 및 백신
US10232029B2 (en) 2014-12-09 2019-03-19 Sanofi Pasteur Compositions comprising N. meningitidis proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis

Also Published As

Publication number Publication date
AU8987598A (en) 1999-03-01
NZ334992A (en) 2001-09-28
NO991558D0 (no) 1999-03-30
CA2267066A1 (en) 1999-02-18
HUP0001451A2 (hu) 2001-04-28
CN1241193A (zh) 2000-01-12
FR2767060B1 (fr) 2000-02-11
JP2001503068A (ja) 2001-03-06
EP0948534A1 (fr) 1999-10-13
HUP0001451A3 (en) 2001-09-28
FR2767060A1 (fr) 1999-02-12
WO1999007741A1 (fr) 1999-02-18

Similar Documents

Publication Publication Date Title
Hamy et al. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA
Krakow et al. Ribonucleic acid polymerase of azotobacter Vinelandii, I. Priming by Polyribonucleotides
Bukrinsky et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
Leiden et al. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells
Tounekti et al. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA
ATE394410T1 (de) Hochspezifische primer, amplifizierungsverfahren und kits
NO976144D0 (no) Sammensetning basert på zirkoniumoksyd og ceriumoksyd, fremgangsmåte for dens fremstilling og anvendelse derav
EP0752887A4 (en) RECOMBINANT IMMUNE WEAKNESS POX VIRUS
WO2000061151A3 (en) Oligodeoxynucleotide and its use to induce an immune response
AU6769590A (en) Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav)
BR9807062A (pt) Purificação ou\e concentração de dna através de separação por filtração de fluxo cruzado de endotoxinas de uma preparação de ácidos nucléicos
BR0006909A (pt) Sequências de nucleotìdeos que codificam o gene de opca
LaPierre et al. Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication
NO991558L (no) Meningokokkvaksine som omfatter valensen til stamme BZ83
PT973794E (pt) Receptores de netrina
Yang et al. Specificity and mechanism of antitermination by Q proteins of bacteriophages λ and 82
GR950300029T1 (en) Dna encoding a human serotonin receptor (5-ht4b)a nd uses thereof.
DE69923587D1 (de) Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden
GB9310657D0 (en) Retrovirus
AP1674A (en) The genome of the HIV-1 inter-subtype (C/B') and use thereof.
ES2216619T3 (es) Vacuna viral.
Allsopp et al. Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35
Leavitt et al. Nucleotide sequence of Bacillus phage Nf terminal protein gene
Schwarz et al. Nested RT-PCR for detection of sandfly fever virus, serotype Toscana, in clinical specimens, with confirmation by nucleotide sequence analysis
JPS643040A (en) Chemical admixture for cement

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application